VERA - Vera Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VERA is currently covered by 10 analysts with an average price target of $78.2. This is a potential upside of $50.1 (178.29%) from yesterday's end of day stock price of $28.1.

Vera Therapeutics's activity chart (see below) currently has 89 price targets and 95 ratings on display. The stock rating distribution of VERA is 80% BUY and 20% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40.92% with an average time for these price targets to be met of 107.5 days.

Highest price target for VERA is $110, Lowest price target is $29, average price target is $78.2.

Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 06-Nov-2026. First documented stock forecast 08-Jun-2021.

Best performing analysts who are covering VERA - Vera Therapeutics:

Dina Ramadane Anupam Rama Liisa Bayko Steven Seedhouse Ed Arce Justin Kim Laura Chico

Currently out of the existing stock ratings of VERA, 20 are a BUY (80%), 5 are a HOLD (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 08-Nov-2024

$29

$-1.14 (-3.78%)

$34

7 days ago
(06-Nov-2026)

12/13 (92.31%)

$-1.14 (-3.78%)

117

Buy Since 05-May-2025

$75

$44.86 (148.84%)

$90

7 days ago
(06-Nov-2026)

0/8 (0%)

$44.86 (148.84%)

Buy Since 15-Aug-2023

$66

$35.86 (118.98%)

$76

7 days ago
(06-Nov-2026)

1/7 (14.29%)

$35.86 (118.98%)

164

Buy Since 12-Jul-2022

$83

$52.86 (175.38%)

$96

2 months 5 days ago
(08-Sep-2026)

6/18 (33.33%)

$47.72 (135.26%)

227

Buy Since 07-Oct-2024

$78

$47.86 (158.79%)

$73

4 months 5 days ago
(08-Jul-2026)

0/4 (0%)

$35.57 (83.83%)

Show more analysts

Please expand the browser size to see the chart

What is VERA (Vera Therapeutics) average time for price targets to be met?

On average it took 108 days for the stock forecasts to be reached, with an average price target met ratio of 40.92%.

Which analyst most recently updated their price target on VERA (Vera Therapeutics)?

Laura Chico

Which analyst has the most public recommendations on VERA (Vera Therapeutics)?

Laura Chico works at WEDBUSH and has 12 price targets and 9 ratings on VERA

Which analyst is the currently most bullish on VERA (Vera Therapeutics)?

Pete Stavropoulos with the highest potential upside of $69.86

Which analyst is the currently most reserved on VERA (Vera Therapeutics)?

Maury Raycroft with the lowest potential downside of -$24.14
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?